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Molecular basis for positive and negative signaling by the natural killer cell
receptor 2B4 (CD244)
Philipp Eissmann, Lisa Beauchamp, Joe Wooters, John C. Tilton, Eric O. Long, and Carsten Watzl
Triggering of 2B4 (CD244) can induce
naturalkiller(NK)–cellactivation,costimu-
lation, or even inhibition of NK–cell activ-
ity. Here, we investigate the molecular
basis for the different signals generated
by 2B4. We show that the ﬁrst immunore-
ceptortyrosine-basedswitchmotif(ITSM)
within the cytoplasmic tail of 2B4 is sufﬁ-
cient for 2B4-mediated NK-cell activation,
whereas the third ITSM can negatively
inﬂuence 2B4 signaling. We further iden-
tify signaling molecules that associate
with 2B4. Signaling lymphocyte activa-
tion molecule–associated protein (SAP)
can bind to all 4 ITSMs of 2B4 in a
phosphorylation-dependent manner. The
phosphorylated third ITSM can addition-
ally recruit the phosphatases SHP-1,
SHP-2, SHIP, and the inhibitory kinase
Csk. SAP acts as an inhibitor of interac-
tions between 2B4 and these negative
regulatorymolecules,explaininghow2B4
inhibits NK-cell activation in the absence
of functional SAP, as occurs in cells from
patients with X-linked lymphoprolifera-
tive syndrome (XLP). Recently, another
function for SAP was proposed: SAP can
recruit the kinase Fyn to the SLAM
(CD150) immune receptor. We now show
that Fyn can also associate with phos-
phorylated 2B4. Finally, we demonstrate
that Fyn and Csk can both phosphorylate
2B4, suggesting a possible mechanism of
2B4 phosphorylation. (Blood. 2005;105:
4722-4729)
© 2005 by TheAmerican Society of Hematology
Introduction
The activity of natural killer (NK) cells is regulated by a multitude
of different surface receptors.1 Depending on their function they
can be divided roughly into activating and inhibiting receptors. In
human NK cells inhibiting receptors are represented by members
of the KIR (killer cell immunoglobulin-like receptor) family and by
the CD94/NKG2 heterodimer.2 Inhibiting receptors recognize
self-major histocompatibility complex (MHC) class I and thereby
protectnormalcellsfromNK-cellattack.3ManyactivatingNK-cell
receptors have been discovered only recently and include NKp30,
NKp44, NKp46, NKp80, NKG2D, DNAM-1, 2B4, NTB-A, and
CS1 (CRACC).4 2B4 binds to CD48, which is widely expressed in
the hematopoietic system.5,6 NTB-A and CS1 (CRACC) are
homophilic,7-9 and NKG2D recognizes several different ligands,
some of which are inducible by cellular stress.10 In most cases,
however, the ligands or structures recognized by activating NK-cell
receptors remain unknown.
Signals by activating and inhibiting receptors are ﬁnely bal-
anced to ensure the tolerance of NK cells toward normal cells.11
This balance can be disturbed by a reduction of the negative signals
or by an enhancement of positive signals, both leading to the
activation of NK cells. A loss of negative signal is usually
observed when target cells lose MHC class I expression, for
example, during viral infection or transformation, and thereby
become sensitive to NK-cell attack.12 Recently, it became clear
that the induced expression of ligands for activating NK-cell
receptors on target cells with normal MHC class I expression is
also sufﬁcient to lead to NK-cell activation.13 This underscores
the ﬁne balance of positive and negative signals that regulate
NK-cell activity.
2B4 was ﬁrst identiﬁed as an activating NK-cell receptor.14 In
humans 2B4 is expressed on all NK cells,  T cells, monocytes,
basophils, and on a subset of CD8 T cells.15-17 On engagement
2B4 can stimulate NK-cell cytotoxicity, production of interferon ,
and granule exocytosis.15,16,18 However, depending on the cell type
and on the stage of differentiation, engagement of 2B4 can have
different outcomes. In addition to being an activating receptor, 2B4
can also enhance signals by other NK receptors such as NKp30 and
NKp46,19 thereby acting as a costimulator. At early stages of
NK-cell differentiation 2B4 can even function as an inhibitory
receptor,20 possibly ensuring the self-tolerance of developing NK
cells. In T cells, triggering of 2B4 does not lead to T-cell activation
by itself,16 but it can augment antigen-speciﬁc T-cell cytotoxicity.21
The CD48-2B4 interaction is also important for the regulation of
CD8 T-cell proliferation.22
2B4 belongs to the signaling lymphocytic activation molecule
(SLAM)–related receptors (SRRs)23 and contains 4 immunorecep-
tor tyrosine-based switch motifs (ITSMs) in its cytoplasmic tail.
Engagement of 2B4 results in a recruitment of the receptor to lipid
rafts,24 specialized membrane domains that play a critical role in
lymphocyte activation. Raft recruitment of 2B4 is essential for the
subsequent tyrosine phosphorylation of the ITSM, which is critical
for 2B4 function. Inhibitory receptors that block 2B4-mediated
NK-cell activation also block raft recruitment and phosphorylation
of the 2B4 receptor,24,25 underscoring the importance of these
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receptor can recruit several signaling molecules such as SAP
(SH2D1A), SHP-2, SHP-1, SHIP, and phosphatidylinositol 3-ki-
nase (PI3K).26-29 SAPis a small signaling molecule composed only
of an SH2 domain. The importance of SAP was revealed by the
ﬁnding that SAP is mutated in X-linked lymphoproliferative
syndrome (XLP), a fatal immune dysfunction associated with the
inability to control Epstein-Barr virus (EBV) infections.30 NK cells
from patients with XLP cannot be activated by 2B4 engage-
ment31-33 and one group reported that 2B4 is inhibitory in the
absence of SAP,27 highlighting the necessity of SAP for the
activating function of 2B4. However, because SAP also associates
with other members of the SRRs, such as SLAM (CD150), CD84,
Ly-9 (CD229), and NTB-A, the pathology of XLP cannot be
explained by the defect in 2B4 signaling alone.34 Interestingly, also
NTB-Ahas been reported to be inhibitory in patients with XLP.35
Why is SAP essential for 2B4 signaling? Transfection experi-
ments have shown that SAPand SHP-2 cannot bind simultaneously
to 2B4,26 suggesting that SAP might function as a natural blocker
of SH2 domain-mediated interactions and might therefore prevent
the interactions between SHP-2 and possibly SHP-1 with 2B4.
However, SAP cannot initiate an activating signaling cascade
simply by keeping negative regulatory signaling molecules from
binding to 2B4. Recent experiments shed light on the function of
SAP in SLAM signaling by demonstrating that SAP recruits and
activates the Src family kinase Fyn through an unusual SH2-SH3
domain interaction.36,37 Because SAP can also associate with
nonphosphorylated SLAM,38 this interaction leads to the Fyn-
mediated phosphorylation of SLAM itself and is crucial for
SLAM-inducedintracellularproteintyrosinephosphorylation.How-
ever, it is unknown if SAP has a similar function in 2B4 signaling.
Here we analyze the early events in 2B4 signaling and propose a
molecular basis for positive and negative signals emanating from
the 2B4 receptor.
Materials and methods
Cells and antibodies
Human polyclonal NK cells were isolated from peripheral blood lympho-
cytes (PBLs) using the magnetic-activated cell sorting (MACS) NK-cell
isolation kit (Miltenyi Biotech, Bergisch Gladbach, Germany). NK cells
were between 90% and 99% CD3, CD56, and 2B4. NK-enriched PBLs
were obtained by coculturing human PBLs with irradiated RPMI 8866 cells
for 10 days in Iscove modiﬁed Dulbecco medium (IMDM) with 10%
human serum.After this, the cells were 55% to 75% CD56. Cell lines used
in this study were 721.221, P815 (both grown in IMDM, 10% fetal calf
serum [FCS]), the human NK-cell line YTS-Eco (gift from G. Cohen,
Massachusetts General Hospital, grown in IMDM, 12.5% FCS, 50 M
2-mercaptoethanol), RPMI 8866 (grown in RPMI 1640, 10% FCS), and
293T (grown in Dulbecco-modiﬁed Eagle medium [DMEM], 10% FCS).
The following antibodies were used: anti-HA (Cell Signaling, Frank-
furt, Germany), immunoglobulin (Ig) G1 control (MOPC-21, Sigma,
Taufkirchen, Germany), anti-SHIP, anti-Syk, anti-Vav, anti-Fyn, biotinyl-
atedantiphosphotyrosine4G10(UpstateCellSignalingSolutions,Charlottes-
ville, VA), anti-SHP-1, anti-SHP-2, anti-Csk, anti-Lyn, anti-Fyn (BD
Transduction Labs, Heidelberg, Germany), anti-2B4 (C1.7; Beckman
Coulter, Krefeld, Germany), horseradish peroxidase (HRP)–conjugated
goat anti–mouse IgG (Jackson ImmunoResearch Laboratories, West Grove,
PA), anti-Lck, peroxidase-conjugated goat anti–rabbit antibodies (Santa
Cruz Biotechnology, Heidelberg, Germany), and peroxidase-conjugated
streptavidin (Amersham, Freiburg, Germany). Rabbit polyclonal anti-SAP
antibodies were raised against the peptide QGTTGIREDPDV and puriﬁed
by afﬁnity puriﬁcation. A monoclonal anti-SAP antibody was produced by
immunizing mice with recombinant histidine (HIS)–tagged SAP. Spleen
cells were fused as previously described.39 The resulting hybridomas were
tested by enzyme-linked immunosorbent assay (ELISA) and Western
blotting. One antibody (anti-SAP.23) was selected and shown to speciﬁcally
detect endogenous levels of SAPinWestern blot analysis of cellular lysates.
The rabbit polyclonal anti-2B4 antibody and the monoclonal anti-NTB-A
antibody have been described.8,25
cDNA constructs and retroviral transduction
An HA-tag was introduced in the 2B4 cDNA after the signal sequence by
polymerase chain reaction (PCR) using the primers AACATCATATG-
GATATTTGCCCTGATACACCTTGAGandCCAGATTATGCTGGATGC-
CAGGGATCAGCTGAC. Deletion mutants were generated by inserting a
stop codon by site-directed mutagenesis at the following positions (base
pair number of the wild-type receptor where the A of the start codon is no.
1): D0 (no. 751), D1 (no. 818), D2 (no. 892), D3 (no. 952). For 2B4 point
mutants the central tyrosine in the ITSM was replaced by phenylalanine by
site-directed mutagenesis. 2B4 mutants were subcloned in the pBABE
retroviral expression vector carrying a puromycin resistance gene. Retrovi-
ral transduction was done using the packaging cell line Phoenix-Eco
(American Type Culture Collection, Manassas, VA).40 Infected YTS-Eco
cells were selected in puromycin and cells positive for anti-HA staining
were further enriched by ﬂuorescence-activated cell sorting (FACS).
Cytotoxicity assay
Target cells were grown to mid-log phase and 5  105 cells were labeled
in 100 L assay medium (IMDM with 10% FCS and penicillin/
streptomycin) with 100 Ci (3.7 MBq) 51Cr for 1 hour at 37°C. Cells
were washed twice in CTL medium and resuspended at 5  104
cells/mL in CTL medium; 5000 target cells/well were used in the assay.
Effector cells were resuspended in CTL medium and, where applicable,
preincubated with antibodies (0.5 g/mL ﬁnal concentration) for 15
minutes at 25°C. After preincubation effector cells were mixed with
labeled target cells in a V-bottom 96-well plate. Maximum release was
determined by incubation in 1% Triton X-100. For spontaneous release,
targets were incubated without effectors in CTL medium alone. All
samples were done in triplicate.After a 1-minute centrifugation at 220 g,
plates were incubated for 4 hours at 37°C. Supernatant was harvested
and 51Cr release was measured in a  counter. Percent speciﬁc release
was calculated as ([experimental releasespontaneous release]/
[maximum releasespontaneous release])  100. The ratio between
maximum and spontaneous release was at least 4 in all experiments.
Peptide pull-down
Peptides corresponding to the 4 ITSMs in 2B4 were obtained from Quality
Controlled Biochemicals (Hopkinton, MA). The sequence of the peptides
was (single amino acid code): (p)Y1, PKEFLTI(p)YEDVKDLK; (p)Y2,
PGGGSTI(p)YSMIQSQS; (p)Y3, SQEPAYTL(p)YSLIQPSR; (p)Y4, PS-
FNSTI(p)YEVIGKSQ; control peptide, CDTLHLIGEHHDGVS. One mil-
ligram of peptide was coupled to 500 L packed Afﬁ-Gel-15 beads
(Bio-Rad, Hercules, CA) according to the manufacturer’s instructions.
Then, 5.6  108 interleukin 2 (IL-2)–expanded human NK cells were lysed
in lysis buffer (0.5% Triton X-100, 20 mM Tris[tris(hydroxymethyl)ami-
nomethane]/HCl, pH 7.4, 150 mM NaCl, 10% glycerin, 2 mM EDTA
[ethylenediaminetetraacetic acid], 1 mM phenylmethylsulfonyl ﬂuoride
[PMSF], 1 mM NaVO4), and lysate was extensively precleared with
empty Afﬁ-Gel-15 beads. Lysate was then split in 9 parts and incubated
with 20 Lpeptide-coupled beads for 4 hours at 4°C. Beads were washed in
lysis buffer and boiled in reducing sodium dodecyl sulfate (SDS) sample
buffer. Three fourths of the sample was analyzed by SDS polyacrylamide
gelelectrophoresis(PAGE)andsilverstaining.41Theremainingsamplewas
split into several samples and analyzed by Western blotting.
Protein analysis
Protein bands of interest were manually excised from the gel, reduced, and
alkylated with iodoacetamide and then digested in situ with trypsin using an
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tide digests were then sequenced using a high-throughput tandem mass
spectrometer (LCQ-DECA ion trap, ThermoFinnigan, San Jose, CA)
equipped with a microelectrospray reversed-phase liquid chromatography
interface. Data were acquired in automated mass spectrometry (MS)/MS
mode using the data acquisition software provided with the mass spectrom-
eter to detect and sequence each peptide as it eluted from the column. The
dynamic exclusion and isotope exclusion functions were used to increase
the number of peptide ions that were analyzed. During the liquid spectrom-
etry (LS)–MS/MS run, typically more than 1000 fragmentation spectra are
collected from each sample and matched against the nonredundant data-
bases (National Center for Biotechnology Information [NCBI]) using the
Sequest software package (ThermoQuest, Watham, MA).
293T cell transfections
Cells (2  106) were grown for 24 hours in 6 mL medium and transfected
by calcium phosphate with up to 10 g total DNA. Cells were harvested 48
hours after transfection and either treated with pervanadate or phosphate-
buffered saline (PBS) alone for 10 minutes at 37°C. Cells were lysed in
ice-cold Triton X-100 lysis buffer for 20 minutes on ice and lysate was
cleared by centrifugation (220 g, 4°C, 15 minutes).
Cell mixing, immunoprecipitation, and Western blotting
Cell mixing was essentially done as described.24 For immunoprecipitation
precleared lysates were ﬁrst incubated for 1 hour at 4°C with 2 g control
IgG1 followed by 2 g speciﬁc antibody, both coupled to recombinant
protein G agarose (Invitrogen, Karlsruhe, Germany). Beads were washed 3
times in ice-cold lysis buffer and boiled in 2.5  reducing (5% SDS, 25%
glycerin, 12.5% 2-ME, 0.156 M Tris/HCl, pH 6.8, 0.01% bromphenol blue)
or nonreducing (no 2-ME) sample buffer. For Western blotting, samples
were separated on either 10% or 12% SDS NuPAGE gels (Invitrogen) and
transferred to a polyvinylidene diﬂuoride (PVDF) membrane (Roth,
Karlsruhe, Germany). The membrane was blocked in PBS with 5% bovine
serum albumin (BSA; Serva, Heidelberg, Germany) for 1 hour at room
temperature and incubated with the indicated antibody overnight at 4°C.
After washing, the membrane was incubated with the respective HRP-
conjugated secondary antibody for 1 hour at room temperature and
developed using Super Signal West Pico (Pierce, Bonn, Germany).
Glutathione-S-transferase (GST) fusion proteins
Thecytoplasmictailof2B4wasampliﬁedbyPCRusingtheforwardprimer
GAA TTC AGG AGAAAG AGG AAG GAG AAG C and reverse primer
CTC GAG CTA GGA ATA AAC ATC AAA GTT CTC C, and subcloned
into the pGEX-4T1 vector (Amersham). Fusion proteins were expressed in
Escherichia coli BL-21 Star (DE3) pLys (Invitrogen) or E coli TKB1
(Stratagene,Amsterdam, The Netherlands) according to the manufacturer’s
instructions as non–tyrosine-phosphorylated or tyrosine-phosphorylated
proteins, respectively. Bacteria were lysed in ice-cold lysis buffer (1%
Triton X-100, 20 mM Tris/HCl, pH 8.0, 500 mM NaCl, 10% glycerol, 1
mM PMSF, 1 mM NaVO4) for 10 minutes on ice. After sonication lysate
was cleared by centrifugation and incubated with a 50% slurry of
glutathione Sepharose beads (Amersham) in lysis buffer rotating for 1 hour
at 4°C. Beads were isolated by centrifugation and stored after washing as a
50% slurry in glycerol at 20°C. Purity and concentration of the isolated
proteins was checked by SDS-PAGE and Coomassie staining using BSA
as a standard.
GST-fusion protein pull-down assays
A total of 12.5  106 NK-cell–enriched PBLs were lysed as described (see
“Peptide pull-down”). Lysate was ﬁrst precleared with glutathione-S-
transferase (GST) beads and then incubated with equal amounts of the
respective fusion protein coupled to glutathione beads for 1 hours at 4°C.
Beads were isolated by centrifugation, washed, boiled in 2.5  reducing
sample buffer, and analyzed by Western blotting.
Results
ITSMs of 2B4 have different functions
Given that triggering of 2B4 can lead to NK-cell activation,
costimulation, and even inhibition, we wanted to analyze which
portions of the 2B4 receptor are necessary for its function. The
cytoplasmic tail of 2B4 contains 4 ITSMs. We generated HA-
tagged versions of 2B4 containing none (D0), one (D1), 2 (D2), 3
(D3), or all 4 (wild-type [WT]) ITSMs and expressed them in the
NK-cell line YTS by retroviral gene transfer at comparable levels
(Figure 1). We then investigated the function of the different 2B4
mutants in a redirected lysis assay. Not surprisingly, the D0 mutant
did not activate NK-cell cytotoxicity (Figure 2A). Triggering of the
D1 mutant led to substantial NK-cell activation, demonstrating that
the ﬁrst ITSM is sufﬁcient for 2B4-mediated NK-cell cytotoxicity.
The activity of the D2 mutant was approximately twice as strong as
that of the D1 mutant. This suggests that the ﬁrst 2 ITSMs are both
contributing to the positive signal transduction of the 2B4 receptor.
Interestingly, the D3 mutant was signiﬁcantly less active compared
to the D2 mutant, indicating that the third ITSM may have a
negative regulatory function in the signal transduction of 2B4.
Adding the fourth ITSM (as in the WT receptor) had only a
marginal positive effect on activation. All different YTS transfec-
tants showed comparable cytotoxicity when triggered through the
NTB-A receptor, excluding variations in the killing capacity of the
different cells (Figure 2B). This demonstrates that the 4 ITSMs in
the cytoplasmic tail of 2B4 are not interchangeable in function;
whereas the ﬁrst and second ITSM are activating, the third ITSM
seems to have a negative inﬂuence on 2B4 activity.This conclusion
was supported by a point mutant carrying an inactive third ITSM
(Y3F). TheY3F mutant, which was expressed at comparable levels
(Figure 1), showed higher activity than the WT 2B4 receptor and
was similar to the D2 mutant, also lacking the third ITSM (Figure
2C), again implying that the third ITSM can have a negative
inﬂuence on 2B4 activity.
Identiﬁcation of signaling molecules associating with the
different ITSMs
To test which signaling molecules bind to the 2B4 receptor we used
synthetic peptides corresponding to each of the 4 ITSMs within
2B4. Each peptide was either nonphosphorylated or phosphory-
lated at the central tyrosine residue of the ITSM. The peptides were
Figure 1. Generation and expression of 2B4 deletion mutants. HA-tagged
deletion mutants of 2B4 containing no (D0), 1 (D1), 2 (D2), 3 (D3), or a mutated third
(Y3F) ITSM (black boxes) were generated by inserting a stop codon or a point
mutation at different positions in the 2B4 cytoplasmic tail. Mutants were expressed in
the NK cell lineYTS by retroviral gene transfer. Expression was monitored by staining
transduced cells with a control antibody (open curve) or an anti-HA antibody (ﬁlled
curve). TM indicates transmembrane domain.
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NK cells. Bound proteins were analyzed by SDS-PAGE and silver
staining and identiﬁed by mass spectrometry-based sequencing.
SAPwasfoundtobindtoall4ITSMpeptidesinaphosphorylation-
dependent manner (Figure 3A-B). We did not obtain sequence
information for the SAP-related molecule EAT-2. No other protein
was speciﬁcally associated with the ﬁrst or the fourth ITSM
peptide. The nonphosphorylated second and third ITSM peptides
showed a stronger binding of heat shock protein 70 (Hsp-70; Figure
3A band no. 7), which is most likely nonspeciﬁc. We could not
obtain sequence information for the protein band no. 6 (Figure 3A).
The phosphorylated third ITSM peptide recruited several proteins
that were identiﬁed to be the inositol phosphatase SHIP, the protein
tyrosine phosphatases SHP-1 and SHP-2, and the c-Src kinase Csk
(Figure 3A). These results were further conﬁrmed by Western blot
analysis using speciﬁc antibodies (Figure 3B). The Western blot
analysis also showed that SHP-2 and Csk can weakly bind to the
phosphorylated second ITSM peptide (Figure 3B). No association
of Lck, Syk, Lyn, or Vav with any of the peptides was detected,
excluding the possibility that SH2 domain-containing proteins
were binding nonspeciﬁcally to the phosphopeptides (Figure 3C).
Thus, we have conﬁrmed previous reports showing binding of SAP,
SHP-1, SHP-2, and SHIP to 2B4.26,27,29 Additionally, we have
identiﬁed the speciﬁc ITSM within 2B4 to which these signaling
molecules bind. We have also demonstrated for the ﬁrst time the
binding of Csk to 2B4.
As an alternative approach to identify 2B4-associated mol-
ecules we produced a GST fusion protein of the 2B4 cytoplasmic
tail in a phosphorylated or nonphosphorylated form. Using these
fusion proteins, we conﬁrmed the phosphorylation-dependent
binding of SHIP, SHP-2, SHP-1, Csk, and SAPto 2B4 (Figure 4A).
This binding was speciﬁc because the SH2 domain-containing
molecule Syk did not bind to the phosphorylated 2B4-GST fusion
protein (Figure 4A). The engagement of 2B4 during the contact of
NK cells with CD48 target cells is the most physiologic way to
stimulate 2B4. Under these conditions we detected the stimulation-
dependent phosphorylation of 2B4 and recruitment of SAP (Figure
4B). However, we did not detect any association between 2B4 and
SHIP, SHP-1, SHP-2, or Csk (data not shown).
The signaling molecules SHIP, SHP-1, SHP-2, and Csk are
involved primarily with the inhibition of signaling events.43
Therefore, the binding of these molecules speciﬁcally to the
phosphorylated third ITSM peptide could explain the negative role
of this ITSM in the signal transduction of the 2B4 receptor, as seen
in Figure 2. However, SAPcan also bind to the third ITSM peptide.
Because neither SAP nor any of the other signaling molecules
associated with the nonphosphorylated peptide, the binding of all
these molecules is dependent on the phosphorylated tyrosine within
Figure 2. Activity of 2B4 mutants. YTS cells expressing different 2B4 mutants
described in Figure 1 were tested in a redirected 51Cr-release assay against P815
target cells in the presence of an anti-HA (A,C) or an anti-NTB-A (B) antibody at
different effector-to-target (E/T) ratios. Speciﬁc lysis in the presence of an isotype
control antibody was less than 2% for all effector cells and E/Tratios.TheY3F mutant
also showed a similar cytotoxic capacity when compared to the wild-type (WT)
receptor (data not shown).
Figure 3. Identiﬁcation of proteins associated with 2B4 ITSM peptides. (A) A
control peptide (c) or peptides corresponding to the 2B4 ITSMs 1 to 4 either
nonphosphorylated (Y1-4) or phosphorylated at the central tyrosine (pY1-4) were
coupled to beads and incubated with lysate from primary human NK cells.Associated
proteins were separated by 10% to 20% SDS-PAGE and visualized by silver staining.
The lower part of the gel was developed longer for greater sensitivity. Protein bands
that differed between the peptides were cut out and identiﬁed by mass spectrometry-
based sequencing. The identiﬁed proteins were SHIP (1), SHP-2 (2), SHP-1 (3), Csk
(4), SAP (5), and Hsp-70 (7). No sequence could be obtained for band no. 6. The
experiment was repeated 3 times with the same results. (B-C) A portion of the
samples described in panel A, including the lysate of primary human NK cells, was
analyzed by 10% to 20% SDS-PAGE followed by Western blotting using the indicated
antibodies.
Figure 4. Association of signaling molecules with the cytoplasmic tail of 2B4.
(A) A fusion protein of the 2B4 cytoplasmic tail with GST was produced either
nonphosphorylated (GST-2B4) or phosphorylated (GST-2B4-P) and coupled to
beads. GST alone was used as a control. Beads were incubated with the lysate of
NK-enriched PBLs and associated proteins were identiﬁed by Western blotting using
the indicated antibodies. (Bi) NK cells were mixed with the CD48 target cell 721.221
for 0 or 5 minutes. 2B4 was immunoprecipitated and analyzed by Western blotting
with an anti-SAP monoclonal antibody (top). The blot was reprobed with an antibody
against 2B4 (middle) and against phosphotyrosine (bottom) to demonstrate 2B4
phosphorylation and equal immunoprecipitation. (ii) Equal SAP expression was
shown by anti-SAP blotting of the lysate.
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molecule can be associated with the third ITSM at a given time. To
test for a possible competition, we coexpressed 2B4 with SAP in
combinationwithSHP-1,SHP-2,orCskandcheckedthephosphor-
ylation-dependent binding of the different signaling molecules to
2B4. In this assay, the presence of SAP could efﬁciently block the
binding of SHP-1, SHP-2, and Csk to 2B4 (Figure 5). The ratio
between expression levels of SAP and SHP-1, SHP-2, and Csk
were comparable to those found in human NK cells (data not
shown) explaining the reason we did not see any association of 2B4
with SHIP, SHP-1, SHP-2, and Csk in Figure 4B. This puts SAP in
a central position to regulate the association of negative regulatory
signaling molecules with the 2B4 receptor and explains how 2B4
can be inhibitory in patients with SAP-defective XLP.
Only SAP associates with the D1 mutant of 2B4
The activity of the D1 mutant, containing only one ITSM domain,
demonstrates that the ﬁrst ITSM is sufﬁcient for 2B4-mediated
NK-cell activation. SAP is the only signaling molecule we could
identify that bound to this ITSM. It was suggested that the function
of SAP is to block the binding of negative regulatory signaling
molecules to SLAM and 2B4. However, this explanation is not
sufﬁcient to explain the ability of the ﬁrst ITSM to induce
2B4-mediated NK-cell activation. To conﬁrm that the D1 mutant
does only recruit SAP, we coexpressed SHP-1, SHP-2, Csk, or SAP
togetherwithdifferent2B4mutantsandcheckedforcoimmunopre-
cipitation of the signaling molecules with 2B4. SHP-1, SHP-2, and
Csk associated only with phosphorylated WT 2B4 but not with the
D0 or the D1 mutants (Figure 6A-C). Pervanadate treatment of the
D1-transfected cells caused extremely weak but detectable tyrosine
phosphorylation of the D1 2B4 receptor (Figure 6F). Only SAP
associated with the D1 mutant of 2B4 (Figure 6D) conﬁrming the
results of the peptide pull-down experiment. The coexpression of
SAP alone with 2B4 induced some 2B4 phosphorylation (Sayos et
al44 and data not shown), explaining the association of SAP with
WT 2B4 in the absence of pervanadate treatment.
Recruitment of Fyn to phosphorylated 2B4
These experiments exclude the possibility that the function of SAP
is based only on its ability as a natural blocker of SH2-domain
interactions. Recently, it was shown that SAP recruits the Src
kinase Fyn to the SLAM receptor through an atypical SH2-SH3
domain interaction.36,37 This suggested that SAP may also have the
ability to recruit Fyn to 2B4. To test this we reprobed the peptide
pull-down Western blot shown in Figure 3 with an anti-Fyn
antibody. A weak but clear association of Fyn with only the
phosphorylated ITSM peptides could be detected (Figure 7A).
After incubation of the 2B4-GST fusion protein with cell lysate
containing SAP and Fyn, we could detect a strong recruitment of
Fyn speciﬁcally to the phosphorylated 2B4-GST fusion protein
(Figure 7B).These data suggest that SAPcan recruit Fyn to the 2B4
receptor. This may be the basis for the activity of the D1 mutant.
Fyn and Csk can phosphorylate 2B4
With Fyn and Csk we now have identiﬁed 2 kinases that can bind to
the 2B4 receptor. To test if either kinase can phosphorylate the 2B4
receptor itself, we expressed Fyn or Csk together with 2B4 and
checked for 2B4 phosphorylation. Overexpression of Fyn resulted
in strong 2B4 phosphorylation (Figure 7C), conﬁrming previous
results.44 We then used point mutants of 2B4 where different
ITSMs were inactivated by tyrosine to phenylalanine mutations to
study which ITSM is phosphorylated by Fyn. Mutations in the ﬁrst,
second, and fourth ITSMs affected 2B4 phosphorylation, suggest-
ing that Fyn preferentially phosphorylates these ITSMs (Figure
7D). Mutating all ITSMs completely abolished Fyn-mediated 2B4
phosphorylation. This demonstrates that Fyn phosphorylates 2B4
only at its ITSM because this mutant still contains 2 non-ITSM
tyrosines in its cytoplasmic tail. Csk was also able to phosphorylate
2B4 (Figure 7C), although the Csk-induced phosphorylation was
reproducibly lower than the Fyn-induced phosphorylation of 2B4.
This demonstrates that both Fyn and Csk can phosphorylate 2B4.
Figure 5. SAP blocks the binding of SHP-1, SHP-2, and Csk to 2B4. 293T cells
were transfected with 2B4, SAP, and SHP-1 (A), SHP-2 (B), or Csk (C) as indicated
and 2B4 phosphorylation was induced by pervanadate treatment. Samples were
immunoprecipitated with a control antibody (IgG1) or with an anti-2B4 antibody and
analyzed by Western blotting using the indicated antibodies (top panels). Blots were
reprobed with an antibody against 2B4 to check for equal immunoprecipitation of 2B4
followed by antiphosphotyrosine blotting to show 2B4 phosphorylation (a representa-
tive blot is shown in panel D). The lysate of the different transfections was analyzed
by anti-SAP, SHP-1, SHP-2, or Csk Western blotting to ensure equal expression
(bottom panels).
Figure 6. The D1 mutant of 2B4 binds only SAP. 293T cells were transfected with
the indicated 2B4 constructs in combination with SHP-1 (A), SHP-2 (B), Csk (C), or
SAP (D). Cells were left untreated or treated with pervanadate (Perv), lysed, and
immunoprecipitated (IP) with a control antibody (IgG1) followed by an antibody
against 2B4.The immunoprecipitate was then analyzed by Western blotting using the
indicated antibodies. Blots were reprobed with an antibody against 2B4 to check for
equal immunoprecipitation of the different 2B4 mutants (a representative blot from
the experiment in panel B is shown in panel E) followed by antiphosphotyrosine
blotting to show 2B4 phosphorylation (a representative blot from the experiment in
panel B is shown in panel F). The antiphosphotyrosine blot of panel D showed 2B4
wild-type (wt) phosphorylation also in the absence of pervanadate treatment (data not
shown). IgH indicates immunoglobulin heavy chain.
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The ITSM is key to the function of SLAM-like receptors. Our data
show that the different ITSMs in the 2B4 cytoplasmic tail are not
interchangeable. Whereas the ﬁrst, second, and fourth ITSMs only
recruit SAPand contribute to 2B4-mediated NK-cell activation, the
third ITSM can additionally recruit SHIP, SHP-1, SHP-2, and Csk
to the 2B4 receptor and negatively inﬂuence 2B4 signaling. This
demonstrates that different ITSMs may have different functions.
The consensus sequence for an ITSM was ﬁrst deﬁned as
TxYxx(V/I) (single amino acid code, where x represents any amino
acid).45 Analysis of the binding preferences of SAP revealed a
preference for the sequence TIYxx(V/I).38 Interestingly, the ﬁrst,
second, and fourth ITSM in 2B4 perfectly match this sequence and
they bind only SAP (Figure 3). The sequence of the third ITSM in
2B4 (TLYSLI) differs in the pY-1 position from the deﬁned
SAP-binding motif. We now show that this motif can also bind
SAP(Figure 3).Whether the leucine at the pY-1 position or another
sequence is responsible for the selective binding of SHIP, SHP-1,
SHP-2, and Csk to the third ITSM will need to be addressed by
further mutational analysis.
The detailed binding analysis presented here also reveals 2
different functions for SAP. At the third ITSM, the function of
SAP may be to block inhibitory SH2 domain interactions, as
previously suggested by others.26,45 This would result in a
regulated binding of inhibitory signaling molecules depending on
the amount of SAPpresent in the cell. In developing NK cells20 and
NK cells from patients with XLP where no functional SAP is
present46-48 SHIP, SHP-1, SHP-2, or Csk would bind strongly to the
third ITSM of 2B4, thereby explaining why 2B4 acts as an
inhibitory receptor in these NK cells. Also, in normal NK cells the
expression of SAPis regulated; viral infections in mice can result in
the up-regulation of SAP in NK cells.44 Preliminary experiments
show that a similar regulation may exist in human NK cells (J. Endt
and C.W., unpublished observation, August 2003). It will be
interesting to investigate if the activity of 2B4 is modulated by
regulated SAPexpression.
Blocking SH2 domain interactions cannot explain how the
binding of SAP to the ﬁrst, second, and fourth ITSMs of 2B4
results in the stimulation of NK-cell cytotoxicity, because no
inhibitory signaling molecules bind to these ITSMs. SAP recruits
Fyn to the SLAM receptor, which is essential for SLAM phosphor-
ylation and function.36,37 We have now shown that Fyn can also be
recruited to the 2B4 receptor (Figure 7). Therefore, SAP-mediated
Fyn recruitment may not only be important for SLAM function but
also for the positive signaling by 2B4. It will be important to
identify which signaling molecules are phosphorylated by Fyn.
Linker for activation of T cells (LAT), Vav, and phospholipase C 
(PLC-) are phosphorylated in response to 2B4 triggering.25,49,50 It
is not known if this is a direct phosphorylation by Fyn or if other
kinases and signaling molecules are necessary for this process.
We detected only weak binding of Fyn to the ITSM peptides of
2B4 (Figure 7A) although all phosphorylated peptides strongly
recruited SAP (Figure 3). Only with the phosphorylated full-length
cytoplasmic tail of 2B4 could we strongly detect Fyn binding
(Figure 7B). One explanation for this discrepancy could be that Fyn
not only binds to SAP but that there is also a direct interaction of
Fyn with the cytoplasmic tail of 2B4, which stabilizes the binding.
SAPrecruits Fyn through an atypical SH2-SH3 domain interaction.
This leaves the SH2 domain of Fyn free to interact with other
phosphorylated tyrosine residues in the cytoplasmic tail of 2B4.
The peptides corresponding to single ITSMs used here were too
short to support any additional interaction. This may explain the
weak binding of SAPto Fyn under our experimental conditions.
Phosphorylation of the activation receptor 2B4 is an early and
essential step in 2B4-mediated NK-cell activation. It is therefore
important to understand the molecular basis of this phosphoryla-
tion. SAP can bind to the ﬁrst ITSM of the SLAM receptor even in
the absence of tyrosine phosphorylation.38 SAPthen recruits Fyn to
induce SLAM phosphorylation. This would result in a positive
feedback loop through more SAP binding and Fyn recruitment
leading to the phosphorylation of downstream signaling molecules.
In the case of 2B4, however, SAP can only bind to the phosphory-
lated receptor. Therefore, the SAP-mediated Fyn recruitment
cannot be the initial step in the phosphorylation of 2B4.
We have recently shown that triggering of 2B4 results in the
recruitment of the receptor to specialized membrane domains
called lipid rafts.24 This raft recruitment is essential for 2B4
phosphorylation. It was recently shown that Lck can phosphorylate
2B4.32 We have now shown that also Csk and Fyn can phosphory-
late 2B4 (Figure 7C). In nonactivated cells both Csk and Fyn are
present in rafts. Csk is bound to Cbp/PAG, inhibiting the activity of
Fyn and other Src family kinases by phosphorylating a negative
regulatory tyrosine residue.51 Following cellular activation, Csk is
released from Cbp/PAG, leaves the rafts, and thereby releases the
inhibition of Src family kinases. It is therefore possible that Csk is
responsible for the initial phosphorylation of 2B4 once the receptor
enters the rafts. Phosphorylation of 2B4 by Csk helps explain the
inhibitory potential of 2B4 in the absence of Fyn recruitment by
SAP, as in XLP. Csk may be sufﬁcient to phosphorylate 2B4,
resulting in the recruitment of SHP-1, SHP-2, and SHIP to the
phosphorylated third ITSM. This suggests yet another way Csk can
exert an inhibitory effect, besides phosphorylation of C-terminal
tyrosine in Src family kinases. In the presence of SAP, the initial
phosphorylation of 2B4 by Csk would lead to the binding of SAP
and the recruitment of Fyn. Fyn could then phosphorylate the other
Figure 7. Fyn is recruited to the phosphorylated 2B4 receptor and Csk and Fyn
can phosphorylate 2B4. (A) A blot shown in Figure 3C was stripped and reprobed
with a rabbit polyclonal anti-Fyn antibody. (B) GST fusion proteins were incubated
with the lysate from NK-cell–enriched PBLs as described in Figure 4 and analyzed by
Western blotting using a monoclonal anti-Fyn antibody. (C) 293T cells were
transfected with 2B4 alone or in combination with Fyn or Csk. Cells were lysed and
immunoprecipitated (IP) with a control antibody (IgG1) followed by an antibody
against 2B4. The immunoprecipitate was then analyzed by antiphosphotyrosine
Western blotting (top blot) and reprobed with an antibody against 2B4 to show equal
immunoprecipitation (bottom blot). (D) 293T cells were transfected with the indicated
2B4 mutants alone () or in combination with Fyn (). Y5F is a control mutant
affecting a tyrosine at the end of the cytoplasmic tail of 2B4, which is not part of an
ITSM sequence. In the Y1234F mutant all ITSMs are mutated. Cells were lysed and
immunoprecipitated (IP) with a control antibody (IgG1) followed by an antibody
against 2B4. The immunoprecipitate was then analyzed by antiphosphotyrosine
Western blotting (top blot) and reprobed with an antibody against 2B4 to show equal
immunoprecipitation (middle blot). Similar expression of Fyn was conﬁrmed by
anti-Fyn Western blotting of the different lysates (bottom blot).
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binding and Fyn recruitment.
This model implies a cooperative phosphorylation of the 2B4
receptor. We observed a very weak but detectable phosphorylation
of the D1 mutant containing just one ITSM (Figure 6F and data not
shown). Interestingly, phosphorylation of the D2 mutant was many
times stronger than that of the D1 mutant and was almost
comparable to that of the D3 mutant and the WT receptor (data not
shown). These data ﬁt the model for 2B4 phosphorylation de-
scribed.After the initial phosphorylation of 2B4, possibly mediated
by Csk, SAP binds to 2B4 and recruits Fyn. In case of the D1
mutant this Fyn recruitment has no additional effect on 2B4
phosphorylation itself because no other ITSM is present in this
mutant. The extent of the D1 mutant phosphorylation is therefore
only dependent on the initial 2B4 phosphorylation by Csk, which is
weaker than the Fyn-mediated phosphorylation (Figure 7C). In
case of the 2B4 mutants containing more than one ITSM, the initial
Fyn recruitment results in the complete phosphorylation of other
ITSMswithinthecytoplasmictailof2B4,makingthephosphoryla-
tion of these 2B4 mutants much stronger than the D1 mutant.
The detailed analysis of 2B4-associated signaling molecules
presented here suggests a molecular basis for positive and negative
signaling by 2B4. Binding of SHIP, SHP-1, SHP-2, and Csk to the
third ITSM explains why 2B4 can inhibit NK-cell activation in the
absence of SAP. In the presence of SAP, binding of negative
regulatory signaling molecules may be inhibited, explaining why
such associations cannot be observed in normal NK cells. More
importantly, Fyn is recruited to the 2B4 receptor resulting in
positive signaling and NK-cell activation. While this paper was in
preparation a report by Chen et al nicely demonstrated that a
SAP-mediated recruitment of Fyn to the 2B4 receptor is essential
for 2B4 phosphorylation and function.52 This report also showed a
functional difference between the different ITSMs of SLAM and
2B4, thereby conﬁrming our results.
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